Related Experiment Video
Updated: May 9, 2025
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.1K
The multiverse of CD46 and oncologic interactions.
The Journal of Clinical Investigation
|May 1, 2025
Summary
CD46, or membrane cofactor protein, is a key molecule in immune responses and a gateway for pathogens. Its emerging role in cancer biology makes it a promising target for novel cancer therapies.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- CD46 (membrane cofactor protein) initially identified as a complement regulator.
- CD46 is expressed on most nucleated cells, with four main isoforms.
- Its functions extend to reproduction, immune modulation, autophagy, and the intracellular complosome.
Purpose of the Study:
- To review the expanded roles of CD46.
- To highlight CD46's emerging significance in cancer biology.
- To discuss CD46 as a therapeutic target in oncology.
Main Methods:
- Literature review of CD46 functions and cancer interactions.
- Analysis of studies linking CD46 expression to cancer progression.
- Examination of CD46-targeted cancer therapeutics.
Main Results:
- CD46 acts as a receptor for numerous pathogens.
- Elevated CD46 expression correlates with malignant transformation and metastasis.
- CD46 is a validated target for oncolytic viruses and antibody-drug conjugates.
Conclusions:
- CD46 has a multifaceted role beyond complement regulation.
- CD46's involvement in cancer presents new therapeutic opportunities.
- Targeting CD46 offers a promising strategy for diverse cancer treatments.
More Related Videos
Related Concept Videos
01:19Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:17The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K